Dying cells are selectively eliminated from the organism by phagocytosis. Previous studies suggested the existence of some other phagocytosis marker(s) that function together with phosphatidylserine, the best-characterized phagocytosis marker. We obtained here a monoclonal antibody named PH2 that inhibited macrophage phagocytosis of late apoptotic or necrotic cells, but not of early apoptotic cells. On the other hand, phagocytosis of cells at any time during the process of apoptosis was inhibitable by phosphatidylserine-containing liposomes. Inhibition occurred even when target cells were preincubated with PH2 and separated from unbound antibodies. Moreover, PH2 bound to apoptotic cells at late stages more efficiently than to those at early stages, and it did not bind to normal cells unless their plasma membrane was permeabilized. These results suggest that the putative PH2 antigen is a novel phagocytosis marker that translocates to the cell surface at late stages of apoptosis, resulting in maximal recognition and engulfment by macrophages. Cell Death and Differentiation (2001) 8, 1113 ± 1122.
Introduction
Apoptosis or programmed cell death plays pivotal roles throughout the life of multicellular organisms. 1 ± 8 Although apoptosis is presumably constantly occurring in many places in the organism, it is difficult to cytologically and histochemically find many apoptosing cells. This is because apoptotic cells are selectively and rapidly eliminated by phagocytosis. 9 Evidence has been accumulated 10, 11 showing that phagocytic elimination of apoptotic cells has a role in passive selfdefense mechanisms, such as the avoidance of inflammation 12 ± 14 and autoimmune disease 15, 16 , as well as in active self-defense mechanisms, such as the elimination of virusinfected cells 17 and antigen presentation. 18 The selectivity of phagocytosis of apoptotic cells is thought to be due to the specific recognition of target cells by phagocytes, most probably through binding of receptors on phagocytes to ligands or markers on apoptotic cells. A variety of molecules have been proposed as candidate markers and their receptors. 11, 19 The membrane phospholipid PS is the best characterized phagocytosis marker, and is considered to be involved in the phagocytosis of many kinds of apoptotic cells. 20 PS is normally restricted to the inner leaflet of the membrane bilayer, and translocates to the outer leaflet upon apoptosis induction. 20 ± 22 Phagocytosis-inducing PS receptors have been identified in several kinds of phagocytes, including endothelial cells, 23 testicular Sertoli cells, 24 and macrophages. 25 Phagocytes have been suggested to change their mechanism of recognizing apoptotic cells depending on their activation state. 26, 27 However, it has been unclear whether regulation of phagocyte recognition of target cells involves changes in the array of markers on the surface of apoptotic cells. We previously found that the extent of phagocytosis continued to increase even after the externalization of PS in apoptotic cells reached a maximal level. 28, 29 These results led us to speculate that the expression of another marker follows externalization of PS in order for cells at late stages of apoptosis to be maximally recognized and engulfed by phagocytes. In this study, we searched for such a marker making use of mAbs.
Results

PS-mediated phagocytosis of apoptotic HF1 cells
When HF1 cells, human Fas-overexpressing HeLa cells, 28 were incubated with the agonistic anti-human Fas mAb CH11, 30 cell viability decreased ( Figure 1A ) and the number of cells with externalized PS increased ( Figure 1B) as the incubation proceeded. When cells were subjected to a phagocytosis assay with thioglycolate-induced mouse peritoneal macrophages, the less-viable cells were more phago-cytosed ( Figure 1A ). Phagocytosis of apoptotic HF1 cells at all time points was partially inhibited by liposomes containing PS, in contrast to the marginal inhibition with liposomes consisting of only PC ( Figure 1C ). This indicated that the phagocytosis of apoptosing HF1 cells was partially mediated by PS exposed on the surface of HF1 cells throughout the apoptosis process. However, the time courses of susceptibility to phagocytosis and PS externalization were not the same: the extent of phagocytosis continued to increase even after PS externalization reached a maximum at 6 h. A population of cells more intensely stained with propidium iodide became significant at 18 h (left panels in Figure 1B ). Such cells corresponded to those detached from culture dishes, as previously reported. 28 We separated those floating cells from the cells remaining attached to dishes, hereafter called respectively`detached' and`attached' cells, at 24 h after apoptosis induction and used the two cell populations in a phagocytosis assay. Detached' cells were much better targets for macrophages than`attached' cells ( Figure 2A ). Although the loss of membrane impermeability made it impossible to assess the PS externalization in`detached' cells, phagocytosis of those cells, as well as of`attached' cells, was apparently mediated by PS ( Figure 2B ). No known phagocytosis markers other than PS seemed to be involved in macrophage recognition of detached' cells, since neither N-acetylglucosamine nor a peptide containing the binding sequence for integrin inhibited phagocytosis ( Figure 2B ). When`attached' cells collected at various times were examined for PS externalization ( Figure  2C ) and their susceptibility to phagocytosis ( Figure 2D ), they were almost equally phagocytosed at lower efficiencies than`d etached' cells by macrophages irrespective of the amount of externalized PS. We thus concluded that the dramatic increase in the extent of phagocytosis at 18 h after apoptosis induction (see Figure 1A ) is attributable to the appearance of detached' cells. From all these results, we inferred the presence of a novel phagocytosis marker on`detached' cells, which together with PS results in the full phagocytosis of those cells by macrophages.
Generation of mAb PH2, which inhibits phagocytosis of`detached' cells
As the first step toward identifying such a novel phagocytosis marker, we generated mAbs against`detached' apoptotic HF1 cells and selected hybridomas producing mAbs that inhibited the phagocytosis of those cells. We finally obtained one hybridoma clone that secreted an IgM antibody. The mAb, which we named PH2, inhibited phagocytosis of`detached' cells in a dose-dependent manner ( Figure 3A , B), but did not influence phagocytosis of`attached' cells ( Figure 3C ). The effective doses of PH2 were within the same range as those of other monoclonal IgM clones with phagocytosis-inhibiting activity, the anti-oxidized low-density lipoprotein mAb clones EO6 and EO12, 31 and the anti-human macrophage PSreceptor mAb clone 217. 25 PH2 seemed to inhibit phagocytosis by binding to the target cells since`detached' apoptotic cells became less susceptible to phagocytosis when they were preincubated with PH2 and separated from unbound antibodies, and this was not the case when macrophages were similarly treated ( Figure 3D ). Target specificity of phagocytosis inhibition by PH2
We next examined whether PH2 inhibits phagocytosis of other apoptotic cells. Human leukemic Jurkat cells were induced to undergo apoptosis by two different anticancer drugs, doxorubicin and bufalin, and subjected to phagocytosis assays in the presence or absence of PH2. Such cells are phagocytosed by peritoneal macrophages prepared from thioglycolate-treated mice in a manner inhibitable by PS liposomes. 32 Phagocytosis of both cell populations by macrophages was clearly inhibited by PH2 ( Figure 4A ). This indicated that inhibition of phagocytosis by PH2 is not restricted to certain cell types or apoptotic stimuli. On the other hand, macrophage phagocytosis of latex beads and IgG-opsonized zymosan particles was not affected by PH2 ( Figure 4B ). We previously reported that treatment with NEM caused PS externalization independently of apoptosis, and that cells subjected to such treatment became susceptible to PS-mediated phagocytosis by macrophages. 28 The addition of PH2 did not affect phagocytosis of NEM-treated HF1 cells, whereas PS liposomes showed clear inhibition ( Figure 4C ). The results of these two experiments indicated that macrophage phagocytosis of non-apoptotic targets is not influenced by PH2. We then tested whether or not phagocytosis of necrotic cells is inhibitable by PH2. HF1 cells were incubated with oligomycin, an ATPase inhibitor, and analyzed for the occurrence of necrosis. Cells with permeabilized plasma membranes with no evidence of chromatin condensation, which are considered to be necrotic, 33 became evident at 6 h after the addition of oligomycin ( Figure 5A ). Macrophages actively phagocytosed such cells; the mean phagocytic indices were 0.67 and 10 for cells assayed at 0 and 12 h, respectively. Phagocytosis of the cells treated with the drug for 12 h was significantly inhibited in the presence of PH2 ( Figure 5B ). These results indicated that necrotic cells are phagocytosed by macrophages in a manner inhibitable by PH2.
In the above experiments,`detached' cells were collected after a 24-h incubation with CH11. We next examined the effect of PH2 on phagocytosis of`detached' cells at various times after apoptosis induction. To our surprise, the extent of inhibition of phagocytosis by PH2 increased as the period of incubation with CH11 was prolonged, and phagocytosis of the cells exposed to CH11 for 12 h or less was not influenced by PH2 ( Figure 6A ). Flow cytometric analysis was then conducted to examine the binding of the F(ab') 2 fragments of PH2 to those cell populations. The amount of bound antibody increased as the duration of apoptosis induction was prolonged ( Figure  6B ), and this coincided well with the increase in the extent of inhibition of phagocytosis by PH2.
The above results collectively indicate that PH2 inhibits macrophage phagocytosis of cells that are at late stages of apoptosis or are undergoing necrotic death.
Characterization of putative PH2 antigen
Phagocytosis of HF1 cells undergoing Fas-mediated apoptosis was inhibited by PS-containing liposomes throughout the process of apoptosis (see Figure 1C) . We therefore determined the relation between PS-mediated and PH2-inhibitable phagocytosis of cells detached from culture containers at late stages of apoptosis. For this purpose, PS liposomes were added to phagocytosis reactions which had been maximally inhibited by PH2. The results showed that the addition of liposomes brought about a further decrease in the extent of phagocytosis (Figure 7 ). This suggested that the two modes of phagocytosis occur independently, and that both modes contribute to the recognition and phagocytosis of late apoptotic cells by macrophages.
The presence and localization of the putative PH2 antigen was examined by an immunofluorescence analysis using the F(ab') 2 fragments of PH2 (Figure 8 ). When normal and apoptotic HF1 cells treated with CH11 for 24 h were analyzed, the antibody bound only to`detached' apoptotic cells. The antigen appeared to be distributed outside the nucleus, and it was not clear whether it was expressed on the cell surface. As expected from the results Figure 3 Effect of mAb PH2 on phagocytosis of apoptotic HF1 cells. (A) Phagocytosis reactions with`detached' HF1 cells (at 24 h) were conducted in the presence or absence of PH2 or control IgM, and the extent of phagocytosis is shown relative to that with no added antibody, which was taken as 100. The mean phagocytic index in the control reaction was 20. (B) Macrophages after phagocytosis reactions in the presence of PH2 (left) or control IgM (300 mg/ml) (right) were examined under a microscope. Fluorescence signals in the top panels indicate engulfed HF1 cells, and the bottom panels show phasecontrast views of the same fields. Bar: 100 mm. (C) The effect of PH2 (300 mg/ ml) on phagocytosis of`attached' and`detached' cells (at 24 h) was examined. The extent of phagocytosis is shown relative to that with no added antibody, which was taken as 100. The mean phagocytic indices in the control reactions were 3.6 and 26 with`attached' and`detached' cells, respectively. (D) Detached' HF1 cells (at 24 h) or macrophages were preincubated with PH2 (300 mg/ml), removed from unbound antibodies, and subjected to phagocytosis assays. The extent of phagocytosis is shown relative to that with no antibody treatment, which was taken as 100. The mean phagocytic index in the control reaction was 16 shown in Figure 4C , NEM-treated cells were negative for the staining. Normal HF1 cells became positive when their plasma membrane was permeabilized, and confocal laser scanning microscopy showed that the antibody seemed to be partially localized in the perinuclear region. These results suggest that the putative PH2 antigen preexists within normal HF1 cells and translocates to the cell surface at late stages of apoptosis. However, we cannot exclude the possibility that the positive staining of`detached' cells is partly due to internalization of the antibody since those cells were permeable to propidium iodide.
Because of the limited utility of IgM antibodies, the nature of the putative PH2 antigen has not been clarified at the present time. ELISA was therefore adopted to get a clue about the identity of the antigen (Figure 9 ). PH2 or its F(ab') 2 fragments bound efficiently to plastic containers that had been coated with total lysates of normal HF1 cells. This reaction was significantly diminished when the lysates were pretreated with trypsin or a-chymotrypsin, but not with neuraminidase or lysozyme. The proteases lost this effect when they were heated or treated with PMSF, a serineprotease inhibitor, before they were added to the lysates. Similarly, fluorescence signals in permeabilized HF1 cells significantly decreased when the cells were treated with achymotrypsin before the addition of the F(ab') 2 fragments of PH2 ( Figure 10A ). This effect was again abrogated by PMSF ( Figure 10B ). These results indicate that the antigenicity of the putative PH2 antigen was sensitive to digestion with proteases.
Discussion
A variety of molecules have been proposed as phagocytosis markers and their receptors. 11, 19 One possible explanation for such diversity might be that distinct populations of apoptotic cells and phagocytes possess distinct markers and receptors, respectively. Another could be that simultaneous usage of multiple recognition systems should help apoptotic cells be more effectively and rapidly eliminated. Previous reports have shown that macrophages utilize distinct sets of phagocytosis receptors depending on their activation states. 26, 27 However, it has not been clear whether dying cells express differing phagocytosis markers depending on their stage in apoptosis. Here we have suggested that apoptosing cells express an additional phagocytosis marker at later stages and become more susceptible to macrophage phagocytosis. We obtained a mAb that inhibits phagocytosis of cells at late but not early stages of apoptosis. Since the mAb, named PH2, bound to normal or early apoptotic cells to only small extents, the cognate antigen is likely to appear on the cell surface at later stages of apoptosis. Phagocytosis of these cells was not affected by inhibitors for known phagocytosis markers except for PS, and was additively inhibited by PS liposomes and PH2. These results strongly suggest that the PH2 antigen is a novel phagocytosis marker which is expressed on the surface of late apoptotic cells and contributes together with PS to the efficient recognition of those cells by macrophages. Figure 4 Effect of PH2 on phagocytosis of various targets. Macrophage phagocytosis was examined in the presence or absence of PH2 (300 mg/ml) with various targets: (A) Jurkat cells induced to undergo apoptosis by anticancer drugs, (B) latex beads and IgG-opsonized zymosan particles, (C) NEM-treated HF1 cells. In (C), the effect of liposomes (1 mM) was also examined. The extent of phagocytosis is shown relative to that with no added inhibitors, which was taken as 100. The mean phagocytic indices in the control reactions were 9.1 (with doxorubicin in A), 27 (with bufalin in A), 82 (with bead in B), 91 (with zymosan in B), and 2.8 (C) The execution of apoptosis does not require the activation of gene expression. 34 Most factors needed for this process are produced by the modification of preexisting molecules, for example, through the cascade of proteolytic activation of caspases. 34 Phagocytosis markers, on the other hand, may be produced without structurally modifying any molecules. Since phagocytosis markers should function on the surface of apoptosing cells, any molecules that exist exclusively inside of normal cells could become such markers simply by being transferred to the cell surface Figure 6 Effect of PH2 on phagocytosis of`detached' HF1 cells at various stages of apoptosis. (A)`Detached' HF1 cells were collected at the indicated times after CH11 addition and subjected to phagocytosis assays in the presence or absence of PH2 (300 mg/ml). The extent of phagocytosis is shown relative to that with no added antibody, which was taken as 100. The mean phagocytic indices in the control reactions were 14 (6 h), 15 (12 h), 18 (18 h), and 26 (24 h). Phagocytic indices with`detached' cells treated with CH11 for less than 6 h were too small to determine the effect of PH2. (B) HF1 cells treated with CH11 for the indicated periods were incubated with propidium iodide and the biotinylated F(ab') 2 fragments of PH2, supplemented with FITCconjugated avidin, and analyzed by flow cytometry. Right panels show binding of the antibody to cells more intensely stained with propidium iodide (top area in the left panels), which corresponded to`detached' cells. Broken lines indicate the results from control experiments using the unlabeled antibody during apoptosis. One such case is the best-characterized phagocytosis marker, PS, a phospholipid that is restricted to the inner leaflet of the membrane bilayer in normal cells, but translocates to the outer leaflet and is exposed to the cell surface upon apoptosis induction. 20 ± 22 Normal cells became positive for the binding of the F(ab') 2 fragments of PH2 when their plasma membrane was permeabilized. This indicated that the putative PH2 antigen preexists in normal cells. It is thus likely that the novel phagocytosis marker proposed here has a mode of surface expression similar to that of PS. The identity of the PH2 antigen is unclear at present. ELISA and immunofluorescence analyses indicated that the antigenicity of the putative PH2 antigen is sensitive to protease digestion. This suggests that the antigen is a protein or some molecule associated with protein, and together with the observation that the perinuclear region gave relatively intense signals in immunofluorescence analysis of permeabilized normal cells, suggests that the PH2 antigen is a protein associated with the membranous apparatus.
Cells undergoing necrosis are actively engulfed by phagocytes. 35 ± 38 Like phagocytosis of apoptotic cells, phagocytosis of necrotic cells is likely to be involved in both passive and active self-defense mechanisms. A few reports indicated that the phagocytosis of necrotic cells is more important for the cross-presentation of antigens by dendritic cells than that of apoptotic cells. 35, 36 The mode of cell ± cell recognition in macrophage phagocytosis of necrotic cells is still unknown. Apoptotic cells often become necrotic when they are left undigested for a long period. If such necrotic cells retain phagocytosis markers that are expressed on their surface during the process of apoptosis, they should still be good targets for phagocytosis. Our results showed that the putative PH2 antigen serves as a marker for the recognition of not only apoptotic but also necrotic cells by macrophages. Since oligomycin-treated cells did not undergo apoptosis, the inhibition of the phagocytosis of those cells by PH2 cannot be attributed to a phagocytosis marker that was carried over from the apoptotic state. Furthermore, the phagocytosis of some necrotic cells appeared to be mediated by PS (our unpublished observations). These results suggest that there may be a similar mechanism for surface expression of phagocytosis markers in cells dying by apoptosis and necrosis.
Materials and Methods
Cell culture and induction of cell death HF1 cells were maintained in minimum essential medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% FBS at 378C in a humidified atmosphere of 5% CO 2 in air, and were induced to undergo apoptosis by addition of CH11 (0.5 mg/ml) (MBL, Nagoya, Japan) as described previously. 28 To prepare the apoptosing cells used for screening hybridomas, HF1 cells were simultaneously treated with CH11 (10 ng/ml) and cycloheximide (50 mg/ml) for 24 h. After apoptosis induction, cells detached from or remaining attached to culture dishes were separately recovered and used in experiments. Both of these`detached' and`attached' cell populations were considered to be apoptotic since they possessed condensed chromatin. HF1 cells were treated with NEM (1 mM) at 378C for 6 min to induce apoptosis-independent PS externalization as described previously. 28 The occurrence of chromatin condensation was assessed by staining cells with Hoechst 33342 followed by examination under a fluorescence/phase-contrast microscope (BX-50; Olympus, Tokyo, Japan). PS externalization was assessed by measuring the binding of FITC-labeled annexin V (Bender MedSystems, Vienna, Austria) using a flow cytometer (EPICS-XL; Coulter, FL, USA) as described previously. 39, 40 Briefly, cells were treated with FITC-annexin V and propidium iodide, and cells less intensely stained with propidium iodide were gated and analyzed for the binding of FITCannexin V. To induce necrosis, HF1 cells were cultured in glucose-free Dulbecco's modified Eagle's medium (Sigma, St. Louis, MO, USA) with 10% FBS in the presence of oligomycin (10 mM) (Sigma). 41 The cells were simultaneously stained with propidium iodide and Hoechst 33342, and examined under a fluorescence microscope. Both are DNA-binding fluorescent dyes, and the former was used to evaluate the permeabilization of the plasma membrane, and the latter to analyze chromatin condensation. Cells positively stained by propidium iodide with no condensed chromatin were considered to be necrotic. 33 Jurkat cells, a human leukemic T-cell line, were grown in RPMI 1640 medium (Nissui Pharmaceuticals) with 10% FBS. For induction of apoptosis, they were incubated with doxorubicin (Sigma) (0.3 mg/ml) for 36 h or with bufalin (Sigma) (10 77 M) for 24 h as described previously. 32 
Macrophage preparation and phagocytosis assay
Macrophages were prepared from the peritoneal fluids of thioglycolateinjected BDF 1 mice (female, 8 ± 12 weeks old) and cultivated on coverslips until use as described previously. 28 The phagocytosis assay was performed essentially as described. 28, 42 Briefly, target cells were labeled with biotin, mixed with macrophages (at a ratio of 10 target cells to one macrophage), and incubated at 378C for 2 h. The mixture was treated with trypsin to remove target cells free from or lightly attached to macrophages. The remaining macrophages were then fixed, permeabilized, and supplemented with FITC-conjugated avidin. The number of macrophages that had engulfed apoptotic cells was determined by examination under a fluorescence/phase-contrast microscope and expressed relative to the total number of macrophages taken as 100, and termed the phagocytic index. The mean and standard deviation of a typical example from at least three independent experiments are presented. To examine the effects of mAbs, apoptotic HF1 cells were preincubated with the culture medium of hybridomas or purified mAbs at 48C for 30 min and subsequently used as the target cells in a phagocytosis assay unless otherwise stated. A mouse myeloma IgM (Calbiochem, La Jolla, CA, USA) was used as a control antibody. Liposomes, peptides, and sugars were directly added to phagocytosis reactions and their effects were determined. Liposomes composed of either PC only (PC liposomes) or a combination of PC and PS at a ratio of 7:3 (PS liposomes) were prepared as described previously. 42 The synthetic peptide H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH was purchased from Bachem Feinchemikalien AG (Bubendrof, Switzerland).
Incorporation of latex beads and zymosan particles by macrophages
Macrophages were incubated with fluorescence-labeled latex beads (Polysciences, Warrington, PA, USA) at 378C for 1 h, washed with PBS, fixed with paraformaldehyde, and analyzed by fluorescence microscopy. Incorporation of zymosan particles was examined as described previously. 29 In brief, macrophages were incubated with fluorescence-labeled, mouse IgG-opsonized zymosan particles (Sigma) and examined under a fluorescence microscope. The extent of incorporation of latex beads and zymosan particles was determined as described for the phagocytic index.
Generation and puri®cation of mAbs
Ten million HF1 cells were detached from culture dishes after a 24-h incubation with CH11 and emulsified with complete Freund's adjuvant (Sigma), and the emulsion was inoculated intraperitoneally into Balb/c mice (female, 6 weeks old). After three serial immunizations, spleen cells were fused with the Balb/c-derived myeloma cell line SP-2. The resulting hybridomas were maintained in RPMI 1640 medium containing 15% FBS at 378C in 7% CO 2 in air, and the culture media were screened for inhibition of phagocytosis of`detached' HF1 cells. Hybridomas that showed inhibitory activity were further cultured and subjected to cloning. The class and subclass of mAbs were determined using a Mouse MonoAB ID/SP Kit (Zymed Laboratories, San Francisco, CA, USA). Ascites fluid was collected from Balb/c mice (male, 6 weeks old), which had been primed with 2,6,10,14-tetramethylpentadecane (Aldrich, Milwaukee, WI, USA) and inoculated with 1610 7 cloned hybridoma cells. A monoclonal IgM antibody, which we named PH2, was purified from the ascites fluid using Ultralink immobilized mannan binding protein (Pierce, Rockford, IL, USA). For preparation of the F(ab') 2 fragments, PH2 was partially purified from the ascites fluid by ammonium sulfate (50%) precipitation and cleaved by pepsin (Sigma) in a citrate buffer (pH 4.2). The generated F(ab') 2 fragments were purified to homogeneity by gel filtration using Sephacryl S-300 (Amersham Pharmacia Biotech, Uppsala, Sweden).
Flow cytometry and immuno¯uorescence
To examine the antibody binding by flow cytometry, cells were incubated with either the biotin-labeled or unlabeled F(ab') 2 fragments of PH2 (250 mg/ml), supplemented with FITC-avidin, and analyzed in a flow cytometer. For immunofluorescence, normal cells and`attached' cells were grown on Lab-Tec chamber slides (Nalge Nunc International, Tokyo, Japan), and`detached' cells and NEM-treated cells were smeared on 3-aminopropyltriethoxysilane-coated slide glasses. For preparation of plasma membrane-permeabilized cells, normal HF1 cells attached to the chamber slides were treated with a solution consisting of 2% paraformaldehyde/0.1% glutaraldehyde/ 0.05% Triton X-100, and then with methanol for 10 min at room temperature. All the cell samples were washed with PBS containing bovine serum albumin, mixed with the biotin-labeled F(ab') 2 fragments (1 mg/ml), supplemented with FITC-avidin, and examined under a fluorescence microscope or a confocal laser scanning microscope (LSM510; Carl Zeiss, Jena, Germany). To examine the effect of proteases, permeabilized HF1 cell samples were incubated with achymotrypsin (Sigma) (10 mg/ml) at 378C in the presence or absence of PMSF (Sigma) (1 mM) prior to the antibody addition.
ELISA
Normal HF1 cells were suspended in a buffer consisting of 1% Nonidet P-40/0.1% sodium deoxycholate/0.1% sodium dodecyl sulfate/0.15 M NaCl/10 mM Tris-HCl, pH 7.4, sonicated briefly, and incubated at 48C for 30 min with gentle agitation. They were then supplemented with dithiothreitol (10 mM) and centrifuged. The supernatants were transferred into multi-well containers (1.25 mg protein per well), and incubated at 48C overnight. The samples were aspirated, and the container was filled with FBS and kept at 378C for 90 min. The containers were washed, supplemented with PH2 (5 mg/ml), and incubated at 378C for 90 min. The wells were then washed and reacted with a peroxidase-labeled anti-mouse IgM antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) at 378C for 90 min. The amount of bound secondary antibody was determined by a colorimetric reaction with o-phenylene diamine. To examine the effect of degradative enzymes, cell lysates were incubated with 1-tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin (10 mg/ ml), a-chymotrypsin (100 mg/ml), neuraminidase (0.1 units/ml), or lysozyme (1 mg/ml) at 308C for 1 h, heated at 1008C for 10 min to inactivate the enzymes, and subjected to the ELISA procedure. Protease treatments were also conducted in the presence of PMSF (1 mM) or with enzymes that had been pre-heated at 1008C for 10 min. A typical example from three independent experiments with similar results is presented.
